About Edaravone API
Therapeutic CategoryCentral Nervous System (CNS)
CAS Number
89-25-8
API Technology
Synthetic
Dose Form
Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Brazil DMF
Mechanism of Action
The mechanism by which RADICAVA exerts its therapeutic effect in patients with ALS is unknown.
Indication
RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS)
Related APIs
Eslicarbazepine Acetate
Central Nervous System (CNS)
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!